| Summary of Net Loss Attributable to Common Stockholders |
The following tables present the calculation of basic and diluted net loss per share (in thousands, except share and per share amounts): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | 2026 | | 2026 | | 2025 | | 2025 | | Redeemable Common Stock | | Common Stock | | Redeemable Common Stock | | Common Stock | | Numerator: | | | | | | | | | Allocation of net loss attributable to common stockholders | $ | (5) | | | $ | (615) | | | $ | (1293) | | | $ | (36,118) | | | Accretion on convertible preferred stock | (7) | | | (841) | | | (29) | | | (819) | | | Accretion on redeemable common stock | 9 | | | (9) | | | 21 | | | (21) | | | | | | | | | | | Allocated net loss attributable to common stockholders, basic | $ | (3) | | | $ | (1,465) | | | $ | (1,301) | | | $ | (36,958) | | | Denominator: | | | | | | | | | Weighted average common shares outstanding, basic | 252,500 | | 28,514,423 | | 562,500 | | 15,716,376 | | Net loss per share attributable to common stockholders, basic | $ | (0.01) | | | $ | (0.05) | | | $ | (2.31) | | | $ | (2.35) | |
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | 2026 | | 2026 | | 2025 | | 2025 | | Redeemable Common Stock | | Common Stock | | Redeemable Common Stock | | Common Stock | | Numerator: | | | | | | | | | Allocation of net loss attributable to common stockholders | $ | (5) | | | $ | (615) | | | $ | (1,293) | | | $ | (36,118) | | | Accretion on convertible preferred stock | (7) | | | (841) | | | (29) | | | (819) | | | Accretion on redeemable common stock | 9 | | | (9) | | | 21 | | | (21) | | | | | | | | | | | Effect of dilutive securities | — | | | — | | | — | | | — | | | Allocated net loss attributable to common stockholders, diluted | $ | (3) | | | $ | (1,465) | | | $ | (1,301) | | | $ | (36,958) | | | Denominator: | | | | | | | | | Weighted average common shares outstanding, basic | 252,500 | | 28,514,423 | | 562,500 | | 15,716,376 | | Effect of dilutive securities | — | | | — | | | — | | | — | | | Weighted average common shares outstanding, diluted | 252,500 | | 28,514,423 | | 562,500 | | 15,716,376 | | Net loss per share attributable to common stockholders, diluted | $ | (0.01) | | | $ | (0.05) | | | $ | (2.31) | | | $ | (2.35) | |
| | | | | | | | | | | | | | | | | | | | | | | | | Six Months Ended June 30, | | 2026 | | 2026 | | 2025 | | 2025 | | Redeemable Common Stock | | Common Stock | | Redeemable Common Stock | | Common Stock | | Numerator: | | | | | | | | | Allocation of net loss attributable to common stockholders | $ | (42) | | | $ | (3,824) | | | $ | (1,183) | | | $ | (32,701) | | | Accretion on convertible preferred stock | (18) | | | (1,678) | | | (59) | | | (1,637) | | | Accretion on redeemable common stock | 22 | | | (22) | | | 42 | | | (42) | | | | | | | | | | | Allocated net loss attributable to common stockholders, basic | $ | (38) | | | $ | (5,524) | | | $ | (1,200) | | | $ | (34,380) | | | Denominator: | | | | | | | | | Weighted average common shares outstanding, basic | 307,610 | | 27,968,200 | | 562,500 | | 15,550,751 | | Net loss per share attributable to common stockholders, basic | $ | (0.12) | | | $ | (0.20) | | | $ | (2.13) | | | $ | (2.21) | |
| | | | | | | | | | | | | | | | | | | | | | | | | Six Months Ended June 30, | | 2026 | | 2026 | | 2025 | | 2025 | | Redeemable Common Stock | | Common Stock | | Redeemable Common Stock | | Common Stock | | Numerator: | | | | | | | | | Allocation of net loss attributable to common stockholders | $ | (42) | | | $ | (3,824) | | | $ | (1,183) | | | $ | (32,701) | | | Accretion on convertible preferred stock | (18) | | | (1,678) | | | (59) | | | (1,637) | | | Accretion on redeemable common stock | 22 | | | (22) | | | 42 | | | (42) | | | | | | | | | | | Effect of dilutive securities | — | | | (2,520) | | | — | | | — | | | Allocated net loss attributable to common stockholders, diluted | $ | (38) | | | $ | (8,044) | | | $ | (1,200) | | | $ | (34,380) | | | Denominator: | | | | | | | | | Weighted average common shares outstanding, basic | 307,610 | | 27,968,200 | | 562,500 | | 15,550,751 | | Effect of dilutive securities | — | | | 109,138 | | 0 | | — | | | Weighted average common shares outstanding, diluted | 307,610 | | 28,077,338 | | 562,500 | | 15,550,751 | | Net loss per share attributable to common stockholders, diluted | $ | (0.12) | | | $ | (0.29) | | | $ | (2.13) | | | $ | (2.21) | |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following table summarizes the common stock equivalents of potentially dilutive outstanding securities excluded from the computation of diluted net loss per share due to their anti-dilutive effect: | | | | | | | | | | | | | June 30, | | 2026 | | 2025 | | Stock options | 94,321 | | 377,012 | | RSUs | 2,000,155 | | 1,361,548 | | PSUs | 104,165 | | 56,391 | | ESPP shares committed | 60,532 | | 44,243 | | Common stock warrants | 1,398,878 | | 10,709,330 | | Preferred stock | 2,872,668 | | 2,872,668 | | Total | 6,530,719 | | 15,421,192 |
|